Cargando…

Adjuvant effects of combination monophosphoryl lipid A and poly I:C on antigen-specific immune responses and protective efficacy of influenza vaccines

Toll-like receptor (TLR) agonists improve vaccine immunogenicity and efficacy, but they are currently unlicensed as adjuvants in influenza vaccines. This study aimed to investigate whether a combination of monophosphoryl lipid A (MPL, a TLR4 agonist) and polyriboinosinic polyribocytidylic acid (poly...

Descripción completa

Detalles Bibliográficos
Autores principales:	Le, Chau Thuy Tien, Ahn, So Yeon, Ho, Thi Len, Lee, Jueun, Lee, Dong-Ha, Hwang, Hye Suk, Kang, Sang-Moo, Ko, Eun-Ju
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382554/ https://www.ncbi.nlm.nih.gov/pubmed/37507413 http://dx.doi.org/10.1038/s41598-023-39210-6

Ejemplares similares

Monophosphoryl Lipid A and Poly I:C Combination Adjuvant Promoted Ovalbumin-Specific Cell Mediated Immunity in Mice Model
por: Ahn, So Yeon, et al.
Publicado: (2021)

Functional NK Cell Activation by Ovalbumin Immunization with a Monophosphoryl Lipid A and Poly I:C Combination Adjuvant Promoted Dendritic Cell Maturation
por: Le, Chau Thuy Tien, et al.
Publicado: (2021)

In vitro effects of monophosphoryl lipid A and Poly I:C combination on equine cells
por: Lee, Dong-Ha, et al.
Publicado: (2023)

Chronic allergic asthma induces T-cell exhaustion and impairs virus clearance in mice
por: Ahn, So Yeon, et al.
Publicado: (2023)

Immunostimulatory effects of marine algae extracts on in vitro antigen‐presenting cell activation and in vivo immune cell recruitment
por: Ho, Thi Len, et al.
Publicado: (2023)

Distinct Effects of Monophosphoryl Lipid A, Oligodeoxynucleotide CpG, and Combination Adjuvants on Modulating Innate and Adaptive Immune Responses to Influenza Vaccination
por: Ko, Eun-Ju, et al.
Publicado: (2017)

Monophosphoryl-Lipid A (MPLA) is an Efficacious Adjuvant for Inactivated Rabies Vaccines
por: Chen, Chen, et al.
Publicado: (2019)

Monophosphoryl Lipid a as an adjuvant for immune therapy? A detailed in vitro comparison to LPS
por: Schülke, Stefan, et al.
Publicado: (2014)

Cell Recruitment and Cytokines in Skin Mice Sensitized with the Vaccine Adjuvants: Saponin, Incomplete Freund’s Adjuvant, and Monophosphoryl Lipid A
por: Vitoriano-Souza, Juliana, et al.
Publicado: (2012)

Combined Adjuvant of Poly I:C Improves Antitumor Effects of CAR-T Cells
por: Di, Shengmeng, et al.
Publicado: (2019)

Immune System Modulation by the Adjuvants Poly (I:C) and Montanide ISA 720
por: Marques, Rodolfo F., et al.
Publicado: (2022)

A systematic review on poly(I:C) and poly-ICLC in glioblastoma: adjuvants coordinating the unlocking of immunotherapy
por: De Waele, Jorrit, et al.
Publicado: (2021)

SARS-CoV-2 sublingual vaccine with RBD antigen and poly(I:C) adjuvant: Preclinical study in cynomolgus macaques
por: Yamamoto, Tetsuro, et al.
Publicado: (2023)

Vaccination by microneedle patch with inactivated respiratory syncytial virus and monophosphoryl lipid A enhances the protective efficacy and diminishes inflammatory disease after challenge
por: Park, Soojin, et al.
Publicado: (2018)

E. coli-Produced Monophosphoryl Lipid a Significantly Enhances Protective Immunity of Pandemic H1N1 Vaccine
por: Nguyen, Quyen Thi, et al.
Publicado: (2020)

Immunogenicity and Protective Capacity of a Virosomal Respiratory Syncytial Virus Vaccine Adjuvanted with Monophosphoryl Lipid A in Mice
por: Kamphuis, Tobias, et al.
Publicado: (2012)

Immunomodulatory effects of poly(I:C)-stimulated exosomes derived from chicken macrophages
por: Hong, Yeojin, et al.
Publicado: (2021)

Induction of Bronchial Tolerance After 1 Cycle of Monophosphoryl-A-Adjuvanted Specific Immunotherapy in Children With Grass Pollen Allergies
por: Rosewich, Martin, et al.
Publicado: (2016)

Synthesis and Evaluation of GM2-Monophosphoryl Lipid A Conjugate as a Fully Synthetic Self-Adjuvant Cancer Vaccine
por: Zhou, Zhifang, et al.
Publicado: (2017)

Immuno-Stimulatory Activity of Escherichia coli Mutants Producing Kdo(2)-Monophosphoryl-Lipid A or Kdo(2)-Pentaacyl-Monophosphoryl-Lipid A
por: Wang, Biwen, et al.
Publicado: (2015)

Poly I:C adjuvanted inactivated swine influenza vaccine induces heterologous protective immunity in pigs
por: Thomas, Milton, et al.
Publicado: (2015)

Mechanism of activation of porcine dendritic cells by an α-D-glucan nanoparticle adjuvant and a nanoparticle/poly(I:C) combination adjuvant
por: Hernandez-Franco, Juan F., et al.
Publicado: (2022)

Intraluminal Administration of Poly I:C Causes an Enteropathy That Is Exacerbated by Administration of Oral Dietary Antigen
por: Araya, Romina E., et al.
Publicado: (2014)

Signal inhibition by a dynamically regulated pool of monophosphorylated MAPK
por: Nagiec, Michal J., et al.
Publicado: (2015)

Specific features of human monocytes activation by monophosphoryl lipid A
por: Chentouh, Ryme, et al.
Publicado: (2018)

INHIBITORY EFFECT OF EMODIN ON RAW 264.7 ACTIVATED WITH DOUBLE STRANDED RNA ANALOGUE POLY I:C
por: Kim, Young-Jin, et al.
Publicado: (2017)

A formulated poly (I:C)/CCL21 as an effective mucosal adjuvant for gamma-irradiated influenza vaccine
por: Sabbaghi, Ailar, et al.
Publicado: (2021)

TLR3 forms a highly organized cluster when bound to a poly(I:C) RNA ligand
por: Lim, Chan Seok, et al.
Publicado: (2022)

A high ratio of IC31(®) adjuvant to antigen is necessary for H4 TB vaccine immunomodulation
por: Aboutorabian, Sepideh, et al.
Publicado: (2015)

Vaccination with toxofilin DNA in combination with an alum-monophosphoryl lipid A mixed adjuvant induces significant protective immunity against Toxoplasma gondii
por: Song, Pengxia, et al.
Publicado: (2017)

Inhibition of Poly(I:C)-Induced Inflammation by Salvianolic Acid A in Skin Keratinocytes
por: Zhang, Qing-Ling, et al.
Publicado: (2019)

Antipurinergic Therapy Corrects the Autism-Like Features in the Poly(IC) Mouse Model
por: Naviaux, Robert K., et al.
Publicado: (2013)

Inactivated Eyedrop Influenza Vaccine Adjuvanted with Poly(I:C) Is Safe and Effective for Inducing Protective Systemic and Mucosal Immunity
por: Kim, Eun-Do, et al.
Publicado: (2015)

Correction to: A formulated poly (I:C)/CCL21 as an effective mucosal adjuvant for gamma‑irradiated influenza vaccine
por: Sabbaghi, Ailar, et al.
Publicado: (2021)

Inefficient TLR4/MD-2 Heterotetramerization by Monophosphoryl Lipid A
por: Casella, Carolyn R., et al.
Publicado: (2013)

Study on the CID Fragmentation Pathways of Deprotonated 4’-Monophosphoryl Lipid A
por: Aissa, Ibrahim, et al.
Publicado: (2021)

Role of adjuvant chemotherapy in the management of stage IC ovarian granulosa cell tumors
por: Nasioudis, Dimitrios, et al.
Publicado: (2019)

Immunotherapeutic effects of intratumoral nanoplexed poly I:C
por: Aznar, M. Angela, et al.
Publicado: (2019)

A Nanoparticle-Poly(I:C) Combination Adjuvant Enhances the Breadth of the Immune Response to Inactivated Influenza Virus Vaccine in Pigs
por: Renu, Sankar, et al.
Publicado: (2020)

Monophosphoryl lipid a attenuates radiation injury through TLR4 activation
por: Guo, Jiaming, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_atpmsq12q9deptikeic5l454tn